Anthony Nguyen, MD
Radiation Oncology · West Hollywood, CANPI 1992293468
Payments from drug & device makers
Across 35 payments — averaging $248.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Rehabilitative Sciences, Inc$4K
- Icotec Medical Inc.$2K
- E.r. Squibb & Sons, L.L.C.$757
- Teleflex LLC$429
- Ipsen Biopharmaceuticals, Inc$282
- Rigel Pharmaceuticals, Inc.$168
- plus $397 from 4 others
Across 3 payments — averaging $867.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$3K
What the payments were for
- Consulting fees$7509%
- Speaking & faculty fees$3504%
- Travel & lodging$7278%
- Food & beverage$2,70231%
- Other$4,17848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Rehabilitative Sciences, Inc | 5 | $4,381 |
| Icotec Medical Inc. | 15 | $2,293 |
| E.r. Squibb & Sons, L.L.C. | 6 | $757 |
| Teleflex LLC | 2 | $429 |
| Ipsen Biopharmaceuticals, Inc | 2 | $282 |
| Rigel Pharmaceuticals, Inc. | 1 | $168 |
| Eisai Inc. | 1 | $132 |
| Beone Medicines USA, Inc. | 1 | $125 |
| Blueprint Medicines Corporation | 1 | $105 |
| Sumitomo Pharma America, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RS 4i Plus Sequential Stimulator$3,434
- icotec BlackArmor Spine System$934
- RS-LBG, RS-FBG$850
- VADER PEDICLE SYSTEM 6.0, SCREW, Carbon/PEEK, POLYAX., FEN., O 5.5 X 45 MM$592
- VADER PEDICLE SYSTEM, ROD, Carbon/PEEK, CURVED, 6.0 R450 X 200 MM$592
- KONG-TL VBR E, EXPANDABLE BODY, L, 19 MM X 27 - 37 MM$592
- KONG-TL VBR, END PLATE, ROUND, L AND SCREW, 12 X 43 MM$592
- KONG-TL VBR, END PLATE, RECTANGULAR, M AND SCREW, 12 X 33 MM$592
- OPDIVO$368
- Barrigel$350
- Pomalyst$270
- Tavalisse$168
- Rezlidhia$168
- GAVRETO$168
- TAZVERIK$148
- ONIVYDE$133
- LENVIMA$132
- TEVIMBRA$125
- AYVAKIT$105
How this compares
$8,707 in reported general payments places this provider in the 80th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 22 | $118 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in West Hollywood
- Howard SandlerWest Hollywood$146K
- Mitchell KamravaWest Hollywood$30K
- Loren Mellla Jolla$10M
- Hyun KimDuarte$6M
- Megan DalyOrange$4.5M
- Percy LeeIrvine$2.4M
- Felix FengSan Francisco$1.8M
- Jeffrey WongDuarte$1.7M
- Arta MonjazebSacramento$1.5M
- Rakesh PatelLos Gatos$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.